COI is incredibly proud to announce that our Co-Director, Prof. Tak Mak, has been ranked by the international academic website Research.com as the 2024 #1 scholar in molecular biology in both Asia and Canada, as well as securing the #10 spot globally. Prof. Mak’s groundbreaking research continues to inspire our Centre’s commitment to improving cancer patient outcomes worldwide. Congratulations on this remarkable achievement! #Immunooncology #Immunology #Oncology #MolecularBiology #CancerResearch #COI
Centre for Oncology and Immunology
Research Services
Hong Kong, Hong Kong 909 followers
About us
Centre for Oncology and Immunology aims to harness the power of biotechnology to develop innovative therapies to combat these hard-to-treat malignancies and bring hope to millions of cancer patients around the world. The Centre’s research team comprises globally renowned researchers who bring with them a wealth of complementary expertise and experience in oncology research, technology adoption, and commercialization. Individually, their research programs have led to major breakthroughs, including the devising of immunotherapy and checkpoint inhibition strategies that have been adopted as anti-cancer treatments, the establishment of next-generation organoid-based cell models for precision oncology, and the development of a diagnostic test for Lynch Syndrome (hereditary colon cancer). The Centre will employ novel functional screens as well as genomic and proteomic techniques to identify novel “druggable” cancer targets. Leveraging the translational and clinical trial expertise of its lead scientists, the Centre will establish a number of advanced technical platforms to facilitate its overall goal of bringing candidate drugs and novel immunotherapy approaches into clinics.
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- Hong Kong, Hong Kong
- Type
- Nonprofit
- Specialties
- Oncology, Immunology, Immuno-Oncology, Functional Genomics, Organoid Platform, T cell-based Immunotherapies, Translational Research, Bioinformatics, Single Cell Technologies, Biomarker Discovery, Drug Discovery, Cancer Biology, Molecular Biology, and CRISPR-based functional screens
Locations
-
Primary
Get directions
Room 1108 -1110, 1202,
Building 17W, Science Park
Hong Kong, Hong Kong 00000, HK
Employees at Centre for Oncology and Immunology
Updates
-
June is Cancer Immunotherapy Month, an annual event to raising awareness and celebrating the remarkable advancements in this transformative cancer treatment. Immunotherapy harnesses the body's immune system to recognize and fight cancer, becoming a standard of care for many cancer types and extending the lives of countless patients. Let's honor the incredible progress made in this field and the hope it brings to those affected by cancer. Learn more about COI: https://www.coinno.hk/ For more information: https://lnkd.in/gdC5c_HV #CancerImmunoTherapyMonth #Immunotherapy #CancerResearch #CRI #COI #Oncology #Immunology
-
-
COI had a successful and inspiring experience at the Asia Summit on Global Health (ASGH) 2024! Our team showcased cutting-edge research, featuring Professor Alan Wong's award-winning CRISPR genome editing tools, and interacted with experts from various sectors. We were excited to connect with potential investors and industry partners from around the world, giving us incredible opportunities to open doors for future collaborations. Read our full article to learn more about COI's participation in this prestigious event! #ASGH2024 #GlobalHealth #Innovation #Investment #COI #CancerResearch #Immunology #Oncology
-
We are ready for the 4th Asia Summit on Global Health! Come meet us at HKCEC (Hall 3FG; Booth 3F-A02) today and tomorrow. At our booth, we will be featuring the award-winning project "CombiSEAL," which is a high-throughput combinatorial mutagenesis platform for protein engineering developed by Prof. Alan Wong and his research team. Don't miss this valuable opportunity to explore our latest inventions! See you there! #ASGH2024 #GlobalHealth #Innovation #Investment #COI #Immunology #Oncology
-
-
Join us at the 4th Asia Summit on Global Health 2024 (ASGH), themed "Innovation．Inclusion．Impact"! Asia's premier health innovation and investment event will feature thematic sessions on the latest trends in the medical sectors this May. COI is honored to be a part of this year's summit once again. Date: 16-17 May 2024 Time: 9 am – 6 pm Venue: Hong Kong Convention and Exhibition Centre (HKCEC) Come and visit our booth at HKCEC (Hall 3FG, Booth 3F-A02)! Don't miss the chance to learn more about COI's mission and projects. #ASGH2024 #GlobalHealth #Innovation #Investment #COI #Immunology #Oncology
-
-
The Annual Meeting of the American Association for Cancer Research (AACR) was successfully held in San Diego from 5 April to 10 April 2024. We are delighted to share that Prof. Tak Mak and Prof. Suet Yi Leung, Co-Directors of COI, were invited to showcase their groundbreaking research and share valuable insights with audience worldwide. Prof. Mak captivated the audience with his research on “Metabolic and neural regulation of immunity and cancer”. Meanwhile, Prof. Leung chaired a session and presented her research findings on “Unraveling the role of cell-cell and cell matrix adhesion dependency in cancer evolution using human gastric organoids”. Other COI researchers also actively took part in the event, including Dr. Kenneth Kwan, Post-doctoral Fellow, presenting his research project titled "BCAT1 promotes HCC metabolic reprogramming and survival through HIF-1α stabilization" during an engaging poster session. We are excited for more progress in our research and to create a supportive environment that helps young scientists grow and succeed. Learn more about COI: https://www.coinno.hk/ #AACR2024 #CancerReasearch #ScientificBreakthroughs #COI #Oncology #Immunology
-
-
🎉 Congratulations!! Prof. Alan Wong and his research team from HKU & COI have been awarded the SILVER MEDAL 🏆 at the 49th International Exhibition of Inventions of Geneva! 👏 👏 The award-winning project, "CombiSEAL," developed by the team, is a high-throughput combinatorial mutagenesis platform for protein engineering. We take great pride in our researchers' exceptional achievements and their dedication to advancing scientific innovation. Once again, kudos to Prof. Alan Wong and the research team for this well-deserved accomplishment! Learn more: https://lnkd.in/gruG3xjE #IEIG2024 #GenevaInventions #ResearchExcellence #COI #Oncology #Immunology
-
-
COI's presence at the First Asia Pacific Symposium on Acute Myeloid Leukaemia reaffirms our dedication to advancing cancer research. Our experts, alongside renowned researchers, discussed the latest advances in AML research and treatment. Learn more below and follow us to stay updated on our latest news and breakthroughs. #AcuteMyeloidLeukemia #BloodCancer #COI #Oncology #Immunology #CancerResearch
Centre for Oncology and Immunology Makes a Strong Presence at the First Asia Pacific Symposium on Acute Myeloid Leukaemia
coinno.hk
-
21 April is AML World Awareness Day. This important day is dedicated to acknowledging the challenges of one of the toughest blood cancers: acute myeloid leukemia (AML). It's a chance to spread awareness about the progress being made in preventing, managing, and treating AML. We stand with those affected by this disease and admire the strength of patients, caregivers, and healthcare professionals. Join us in raising awareness and showing your support on AML World Awareness Day! For more information: https://know-aml.com/ Learn more about COI: https://www.coinno.hk/ #AMLWorldAwarenessDay #AcuteMyeloidLeukemia #BloodCancer #COI #Oncology #Immunology
-
-
The 49th International Exhibition of Inventions Geneva (IEIG) is just around the corner! From 17 April to 21 April, Geneva will be filled with the most innovative minds from around the world. COI is privileged to participate in this prestigious event and showcase our innovative research. We are looking forward to achieving fruitful results. #IEIG2024 #Invention #Innovation #Geneva #COI #Oncology #Immunology
-